The value of health screening lies in helping people better understand their own physical condition. Every screening is an opportunity to listen to your body, making it clearer which areas need improvement and which habits need to change.

Health experts at ProteinT, headquartered in the Tianjin Port Free Trade Zone, note that the lungs, stomach, liver and cardiovascular system are vital organs. Regular systematic screening helps detect risk factors early and prevent problems before they occur. Cancer screening of vital organs is a proactive anti-cancer measure: by actively testing when there are no unusual symptoms, the goal is to detect early-stage cancer and precancerous lesions and achieve early detection, diagnosis and treatment.

In cardiovascular screening, blood-lipid testing acts like a magnifying glass. Detecting dyslipidemia and monitoring changes in lipid levels helps assess the risk of atherosclerotic cardiovascular disease (ASCVD) and guides physicians in active prevention and treatment.

ASCVD — including coronary heart disease, cerebral thrombosis and peripheral arterial stenosis — develops insidiously and silently damages cardiovascular health. Dyslipidemia is the principal driver of atherosclerosis, with hypertension, smoking, diabetes and obesity as contributing factors. Detecting and treating dyslipidemia early can prevent or delay disease progression.

To support systematic screening, ProteinT recently launched related products that use blood and urine tests to deliver precise analysis and risk detection, enabling earlier health intervention. Among them, ELISA™-ProEn provides organ-wide risk assessment from a single blood test, covering lung, gastric, liver and cardiovascular risk.